- Type / Class
- Equity / COMMON STOCK
- Shares outstanding
- 181,672,212
- Total 13F shares
- 58,654,950
- Share change
- -1,667,943
- Total reported value
- $144,864,309
- Put/Call ratio
- 116%
- Price per share
- $2.47
- Number of holders
- 118
- Value change
- -$2,708,584
- Number of buys
- 64
- Number of sells
- 64
Quarterly Holders Quick Answers
What is CUSIP 74168J101?
CUSIP 74168J101 identifies PRME - Prime Medicine, Inc. - COMMON STOCK in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 74168J101:
Top shareholders of PRME - Prime Medicine, Inc. - COMMON STOCK (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| GV 2019 GP, L.L.C. |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
11,862,498
|
$177,594,643 | — | 20 Jun 2023 | |
| FMR LLC |
3/4/5
13F
|
Other* · Company |
2.1%
from 13F
|
8,462,946
|
$126,699,612 | — | 24 Oct 2022 | |
| David R. Liu |
3/4/5
|
10%+ Owner |
11%
|
20,240,945
|
$50,920,145 | +$163,017 | 30 Jun 2025 | |
| Alphabet Inc. |
13F
|
Company |
8.3%
|
15,062,498
|
$29,974,371 | — | 31 Mar 2025 | |
| GV 2023 GP, L.L.C. |
3/4/5
|
Member of 10% Group |
—
class O/S missing
|
3,200,000
|
$20,000,000 | — | 20 Feb 2024 | |
| Keith Michael Gottesdiener |
3/4/5
|
Exhibit 24 - Power of Attorney; Title: President and Chief Executive Officer, Director |
—
mixed-class rows
|
3,343,337
mixed-class rows
|
$19,020,856 | — | 08 May 2025 | |
| Newpath Partners, L.P. |
13D/G
|
— |
4.7%
|
6,105,679
|
$9,769,086 | $0 | 31 Dec 2024 | |
| BlackRock, Inc. |
13F
|
Company |
2.4%
|
4,306,211
|
$8,569,360 | — | 31 Mar 2025 | |
| T. Rowe Price Investment Management, Inc. |
13F
|
Company |
2.3%
|
4,143,096
|
$8,245,000 | — | 31 Mar 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
2%
|
3,641,348
|
$7,246,282 | — | 31 Mar 2025 | |
| ARK Investment Management LLC |
13F
|
Company |
1.7%
|
3,095,172
|
$6,159,392 | — | 31 Mar 2025 | |
| Amova Asset Management Americas, Inc. |
13F
|
Company |
1.6%
|
2,926,023
|
$5,822,786 | — | 31 Mar 2025 | |
| Sumitomo Mitsui Trust Group, Inc. |
13F
|
Company |
1.6%
|
2,926,023
|
$5,822,786 | — | 31 Mar 2025 | |
| Redmile Group, LLC |
13F
|
Company |
1.1%
|
2,074,350
|
$4,127,957 | — | 31 Mar 2025 | |
| MWG Management Ltd. |
13F
|
Company |
0.99%
|
1,792,210
|
$3,566,498 | — | 31 Mar 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.98%
|
1,779,945
|
$3,542,091 | — | 31 Mar 2025 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.86%
|
1,567,192
|
$3,120,000 | — | 31 Mar 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.84%
|
1,526,530
|
$3,038,671 | — | 31 Mar 2025 | |
| STATE STREET CORP |
13F
|
Company |
0.63%
|
1,145,305
|
$2,279,157 | — | 31 Mar 2025 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
0.57%
|
1,028,466
|
$2,046,647 | — | 31 Mar 2025 | |
| Greenwich Wealth Management LLC |
13F
|
Company |
0.45%
|
819,001
|
$1,630,000 | — | 31 Mar 2025 | |
| FARALLON CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.41%
|
750,000
|
$1,492,500 | — | 31 Mar 2025 | |
| EcoR1 Capital, LLC |
13F
|
Company |
0.39%
|
700,000
|
$1,393,000 | — | 31 Mar 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.29%
|
527,309
|
$1,049,345 | — | 31 Mar 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.28%
|
503,697
|
$1,002,357 | — | 31 Mar 2025 | |
| MOORE CAPITAL MANAGEMENT, LP |
13F
|
Company |
0.28%
|
500,000
|
$995,000 | — | 31 Mar 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.25%
|
447,600
|
$890,724 | — | 31 Mar 2025 | |
| Samsara BioCapital, LLC |
13F
|
Company |
0.22%
|
405,228
|
$806,404 | — | 31 Mar 2025 | |
| Casdin Capital, LLC |
13F
|
Company |
0.2%
|
367,175
|
$730,678 | — | 31 Mar 2025 | |
| Bollard Group LLC |
13F
|
Company |
0.2%
|
361,136
|
$719,000 | — | 31 Mar 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.2%
|
355,176
|
$706,803 | — | 31 Mar 2025 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.14%
|
258,770
|
$514,952 | — | 31 Mar 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.14%
|
251,399
|
$500,284 | — | 31 Mar 2025 | |
| AQR CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.13%
|
243,795
|
$485,152 | — | 31 Mar 2025 | |
| CHELSEA COUNSEL CO |
13F
|
Company |
0.11%
|
208,210
|
$414,338 | — | 31 Mar 2025 | |
| Nuveen, LLC |
13F
|
Company |
0.03%
|
59,402
|
$373,689 | — | 31 Mar 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.09%
|
155,992
|
$310,425 | — | 31 Mar 2025 | |
| GSA CAPITAL PARTNERS LLP |
13F
|
Company |
0.08%
|
153,273
|
$305,000 | — | 31 Mar 2025 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.08%
|
142,619
|
$283,812 | — | 31 Mar 2025 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.07%
|
126,846
|
$252,424 | — | 31 Mar 2025 | |
| FIL Ltd |
13F
|
Company |
0.07%
|
121,017
|
$240,824 | — | 31 Mar 2025 | |
| UBS Group AG |
13F
|
Company |
0.06%
|
117,680
|
$234,183 | — | 31 Mar 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.06%
|
112,926
|
$224,722 | — | 31 Mar 2025 | |
| Palumbo Wealth Management LLC |
13F
|
Company |
0.05%
|
95,462
|
$189,970 | — | 31 Mar 2025 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.05%
|
90,819
|
$180,730 | — | 31 Mar 2025 | |
| IQ EQ FUND MANAGEMENT (IRELAND) Ltd |
13F
|
Company |
0.05%
|
89,870
|
$178,841 | — | 31 Mar 2025 | |
| Green Alpha Advisors, LLC |
13F
|
Company |
0.05%
|
83,467
|
$166,099 | — | 31 Mar 2025 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.05%
|
81,900
|
$162,971 | — | 31 Mar 2025 | |
| Vestmark Advisory Solutions, Inc. |
13F
|
Company |
0.04%
|
78,599
|
$156,412 | — | 31 Mar 2025 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.04%
|
76,000
|
$151,240 | — | 31 Mar 2025 |
Institutional Holders of Prime Medicine, Inc. - COMMON STOCK (PRME) as of Q2 2025
As of 30 Jun 2025,
Prime Medicine, Inc. - COMMON STOCK (PRME) was held by
118 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
58,654,950 shares.
The largest 10 holders included
Alphabet Inc., T. Rowe Price Investment Management, Inc., BlackRock, Inc., FMR LLC, VANGUARD GROUP INC, ARK Investment Management LLC, Redmile Group, LLC, MWG Management Ltd., Sumitomo Mitsui Trust Group, Inc., and Nikko Asset Management Americas, Inc..
This page lists
118
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
121
Q2 2025 holders
118
Holder diff
-3
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 Value $ | Q2 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.